首页 > 最新文献

Georgian medical news最新文献

英文 中文
HEAVY METAL TOXICITY VERSUS TRACE ELEMENT PROTECTION IN WOMEN'S REPRODUCTIVE HEALTH - A SYSTEMATIC REVIEW. 重金属毒性与妇女生殖健康中的微量元素保护——系统综述。
Q4 Medicine Pub Date : 2025-12-01
A Amanzholkyzy, Y Sagidanova, E Stankevicius, A Donayeva, U Sarsengali

Background: Environmental exposures are increasingly linked to reproductive dysfunctions such as endometriosis, ovarian insufficiency, and polycystic ovary syndrome (PCOS). Through endocrine disruption, oxidative stress, and epigenetic pathways, heavy metals (such as cadmium [Cd], lead [Pb], mercury [Hg], and arsenic [As]) and trace elements (such as zinc [Zn], copper [Cu], and selenium [Se]) may affect female fertility. Nevertheless, there are still few integrated assessments that address their combined consequences. The goal is to perform a critical evaluation and systematic analysis of epidemiological data about the link between reproductive health issues in women of reproductive age and exposure to heavy metals and trace elements.

Methods: A comprehensive literature search was carried out in PubMed, Scopus, Google Scholar, and Web of Science to locate articles published between 2010 and 2024. Included were observational human studies that looked at correlations between metal exposure and the reproductive results of females. The study's quality was assessed using the Newcastle-Ottawa Scale (NOS), and the review process adhered to PRISMA guidelines.

Findings: A total of twenty-three studies were included in the review: eleven case-control studies, eight cross-sectional studies, three cohort studies, and one analytical study. Cd, Pb, As, Hg, Cu, and Zn were the most frequently evaluated elements; these were usually detected in biological samples such blood, serum, or follicular fluid. While low Zn and Se levels were linked to endometrial diseases and a reduced ovarian reserve, elevated levels of Cd, Pb, and As were linked to an increased risk of PCOS and endometriosis. Inflammation and endocrine dysregulation were inversely correlated with protective trace elements, especially zinc and selenium. 17 studies had a high-quality rating (NOS score ≥7).

Conclusions: One important and controllable risk factor for the reproductive health of women is exposure to hazardous metals. It seems that preserving reproductive function depends on striking a balance between harmful and necessary components. To elucidate dose-response connections, synergistic effects, and possible therapeutic options, further prospective and mechanistic research is required.

背景:环境暴露与子宫内膜异位症、卵巢功能不全和多囊卵巢综合征(PCOS)等生殖功能障碍的关系越来越密切。通过内分泌干扰、氧化应激和表观遗传途径,重金属(如镉[Cd]、铅[Pb]、汞[Hg]和砷[as])和微量元素(如锌[Zn]、铜[Cu]和硒[Se])可能影响女性生育能力。然而,仍然很少有综合评估处理它们的综合后果。目标是对关于育龄妇女生殖健康问题与接触重金属和微量元素之间的联系的流行病学数据进行批判性评价和系统分析。方法:在PubMed、Scopus、谷歌Scholar、Web of Science等数据库中进行综合文献检索,定位2010 - 2024年间发表的文章。其中包括观察性人体研究,研究金属暴露与女性生殖结果之间的关系。研究质量采用纽卡斯尔-渥太华量表(NOS)进行评估,审查过程遵循PRISMA指南。结果:本综述共纳入23项研究:11项病例对照研究、8项横断面研究、3项队列研究和1项分析研究。Cd、Pb、As、Hg、Cu和Zn是最常被评价的元素;这些通常在血液、血清或卵泡液等生物样品中检测到。低锌和低硒水平与子宫内膜疾病和卵巢储备减少有关,而高镉、铅和砷水平与多囊卵巢综合征和子宫内膜异位症的风险增加有关。炎症和内分泌失调与保护性微量元素呈负相关,尤其是锌和硒。17项研究获得高质量评分(NOS评分≥7)。结论:有害金属接触是影响妇女生殖健康的一个重要的可控危险因素。似乎维持生殖功能取决于在有害成分和必要成分之间取得平衡。为了阐明剂量-反应关系、协同效应和可能的治疗选择,需要进一步的前瞻性和机制研究。
{"title":"HEAVY METAL TOXICITY VERSUS TRACE ELEMENT PROTECTION IN WOMEN'S REPRODUCTIVE HEALTH - A SYSTEMATIC REVIEW.","authors":"A Amanzholkyzy, Y Sagidanova, E Stankevicius, A Donayeva, U Sarsengali","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Environmental exposures are increasingly linked to reproductive dysfunctions such as endometriosis, ovarian insufficiency, and polycystic ovary syndrome (PCOS). Through endocrine disruption, oxidative stress, and epigenetic pathways, heavy metals (such as cadmium [Cd], lead [Pb], mercury [Hg], and arsenic [As]) and trace elements (such as zinc [Zn], copper [Cu], and selenium [Se]) may affect female fertility. Nevertheless, there are still few integrated assessments that address their combined consequences. The goal is to perform a critical evaluation and systematic analysis of epidemiological data about the link between reproductive health issues in women of reproductive age and exposure to heavy metals and trace elements.</p><p><strong>Methods: </strong>A comprehensive literature search was carried out in PubMed, Scopus, Google Scholar, and Web of Science to locate articles published between 2010 and 2024. Included were observational human studies that looked at correlations between metal exposure and the reproductive results of females. The study's quality was assessed using the Newcastle-Ottawa Scale (NOS), and the review process adhered to PRISMA guidelines.</p><p><strong>Findings: </strong>A total of twenty-three studies were included in the review: eleven case-control studies, eight cross-sectional studies, three cohort studies, and one analytical study. Cd, Pb, As, Hg, Cu, and Zn were the most frequently evaluated elements; these were usually detected in biological samples such blood, serum, or follicular fluid. While low Zn and Se levels were linked to endometrial diseases and a reduced ovarian reserve, elevated levels of Cd, Pb, and As were linked to an increased risk of PCOS and endometriosis. Inflammation and endocrine dysregulation were inversely correlated with protective trace elements, especially zinc and selenium. 17 studies had a high-quality rating (NOS score ≥7).</p><p><strong>Conclusions: </strong>One important and controllable risk factor for the reproductive health of women is exposure to hazardous metals. It seems that preserving reproductive function depends on striking a balance between harmful and necessary components. To elucidate dose-response connections, synergistic effects, and possible therapeutic options, further prospective and mechanistic research is required.</p>","PeriodicalId":12610,"journal":{"name":"Georgian medical news","volume":" 369","pages":"210-216"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146194740","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
TRANSFORMING MEDICAL EDUCATION IN KAZAKHSTAN: THE POTENTIAL OF VIRTUAL REALITY FOR ENHANCING THE LEARNING EXPERIENCE. 改变哈萨克斯坦的医学教育:虚拟现实增强学习经验的潜力。
Q4 Medicine Pub Date : 2025-12-01
M Myrzakhanova, G Berdesheva, K Rustemova, Sh Kulbayeva, Y Lissitsyn, Zh Tleubergenova

Background: The potential of virtual reality (VR) in medical education in Kazakhstan proved substantial, offering innovative learning methods and creating secure, interactive training environments that facilitated the acquisition of both theoretical knowledge and practical skills.

Material and methods: This study aimed to evaluate the application and effectiveness of virtual reality in medical education through a survey conducted with 53 students and 20 teachers. To assess the perceptions and satisfaction with VR in medical education, a survey was conducted utilizing a scale from 1 to 10.

Results: Findings from the survey revealed that students perceived significant advantages in using virtual reality to grasp complex medical concepts and hone clinical skills. They appreciated the opportunity to apply theoretical knowledge in practice, the availability of high-quality content across various disciplines, and the safe learning conditions provided.

Conclusion: Teachers recognized virtual reality as a valuable educational tool but highlighted some challenges, including insufficient training and limited access to equipment. Addressing these obstacles is crucial for the successful integration of virtual reality into training programs, thereby unlocking its full potential and enhancing educational outcomes.

背景:事实证明,虚拟现实(VR)在哈萨克斯坦医学教育中的潜力巨大,它提供了创新的学习方法,创造了安全、互动的培训环境,促进了理论知识和实践技能的获取。材料与方法:本研究旨在通过对53名学生和20名教师的调查,评估虚拟现实在医学教育中的应用和有效性。为了评估对医学教育中虚拟现实的看法和满意度,我们进行了一项调查,采用了从1到10的量表。结果:调查结果显示,学生认为使用虚拟现实在掌握复杂医学概念和磨练临床技能方面具有显著优势。他们欣赏将理论知识应用于实践的机会,各种学科的高质量内容的可用性,以及提供的安全学习条件。结论:教师们认识到虚拟现实是一种有价值的教育工具,但也强调了一些挑战,包括培训不足和设备有限。解决这些障碍对于将虚拟现实成功整合到培训计划中至关重要,从而释放其全部潜力并提高教育成果。
{"title":"TRANSFORMING MEDICAL EDUCATION IN KAZAKHSTAN: THE POTENTIAL OF VIRTUAL REALITY FOR ENHANCING THE LEARNING EXPERIENCE.","authors":"M Myrzakhanova, G Berdesheva, K Rustemova, Sh Kulbayeva, Y Lissitsyn, Zh Tleubergenova","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>The potential of virtual reality (VR) in medical education in Kazakhstan proved substantial, offering innovative learning methods and creating secure, interactive training environments that facilitated the acquisition of both theoretical knowledge and practical skills.</p><p><strong>Material and methods: </strong>This study aimed to evaluate the application and effectiveness of virtual reality in medical education through a survey conducted with 53 students and 20 teachers. To assess the perceptions and satisfaction with VR in medical education, a survey was conducted utilizing a scale from 1 to 10.</p><p><strong>Results: </strong>Findings from the survey revealed that students perceived significant advantages in using virtual reality to grasp complex medical concepts and hone clinical skills. They appreciated the opportunity to apply theoretical knowledge in practice, the availability of high-quality content across various disciplines, and the safe learning conditions provided.</p><p><strong>Conclusion: </strong>Teachers recognized virtual reality as a valuable educational tool but highlighted some challenges, including insufficient training and limited access to equipment. Addressing these obstacles is crucial for the successful integration of virtual reality into training programs, thereby unlocking its full potential and enhancing educational outcomes.</p>","PeriodicalId":12610,"journal":{"name":"Georgian medical news","volume":" 369","pages":"44-51"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146194493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
HYPERCORTICISM IN THE PATHOGENESIS OF ACUTE RADIATION SICKNESS AND CONDITIONS OF INCREASED RADIORESISTANCE. 高皮质在急性放射病的发病机制和放射抵抗增加的条件。
Q4 Medicine Pub Date : 2025-12-01
N Omelchuk

Objective: To investigate the role of hypercorticism in the pathogenesis of acute radiation sickness (ARS) and under conditions of increased radioresistance, assessing the theoretical and clinical significance of impaired protein-steroid interactions.

Materials and methods: An analysis was conducted of experimental data from irradiated animal models: chinchilla rabbits (n=20), dogs (n=15), WISTAR rats (n=63), guinea pigs (n=49), and BALB/c mice (n=32). Some animals underwent adrenal autotransplantation. Fluorometric and gel filtration methods were used to assess protein-steroid interactions; total-body γ-irradiation was administered at doses inducing grade IV ARS. Data were statistically processed using Student's t-test.

Results: A biphasic adrenocortical response to radiation was observed in most species, whereas rabbits exhibited a monophasic decline in corticosteroid levels. During the peak of ARS, impaired corticosteroid-binding globulin (CBG) function led to increased levels of free, biologically active corticoids, even with normal or reduced total 11-oxycorticosteroids. A consistent radiobiological pattern was established: an increase in the free hormone fraction due to diminished CBG binding capacity. Adrenal autotransplantation prior to irradiation reduced corticoid levels, enhanced CBG binding capacity during ARS, and decreased free corticoid concentrations, resulting in a protective effect and increased radioresistance.

Conclusion: The findings underscore the critical role of corticosteroid regulation and CBG functional status in the body's response to radiation exposure. Modulation of adrenal activity and correction of protein-steroid interactions may be considered a promising strategy for enhancing radioresistance.

目的:探讨高皮质在急性放射病(ARS)发病机制中的作用,以及在放射抵抗增强的情况下,评估蛋白-类固醇相互作用受损的理论和临床意义。材料与方法:对辐照动物模型的实验数据进行分析:栗鼠(n=20)、狗(n=15)、WISTAR大鼠(n=63)、豚鼠(n=49)和BALB/c小鼠(n=32)。一些动物进行了肾上腺自体移植。荧光法和凝胶过滤法用于评估蛋白质-类固醇相互作用;全身γ辐照剂量诱导IV级ARS。数据采用学生t检验进行统计学处理。结果:在大多数物种中观察到双相肾上腺皮质对辐射的反应,而家兔表现出皮质类固醇水平的单相下降。在ARS的高峰期,皮质类固醇结合球蛋白(CBG)功能受损导致游离的、具有生物活性的皮质激素水平升高,即使总11-氧皮质激素正常或减少也是如此。建立了一致的放射生物学模式:由于CBG结合能力降低,游离激素部分增加。辐照前的肾上腺自体移植降低了皮质激素水平,增强了ARS期间CBG的结合能力,并降低了游离皮质激素浓度,从而产生保护作用并增加了放射抵抗。结论:这些发现强调了皮质类固醇调节和CBG功能状态在人体对辐射暴露的反应中的关键作用。肾上腺活性的调节和蛋白质-类固醇相互作用的纠正可能被认为是增强放射抵抗的有前途的策略。
{"title":"HYPERCORTICISM IN THE PATHOGENESIS OF ACUTE RADIATION SICKNESS AND CONDITIONS OF INCREASED RADIORESISTANCE.","authors":"N Omelchuk","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the role of hypercorticism in the pathogenesis of acute radiation sickness (ARS) and under conditions of increased radioresistance, assessing the theoretical and clinical significance of impaired protein-steroid interactions.</p><p><strong>Materials and methods: </strong>An analysis was conducted of experimental data from irradiated animal models: chinchilla rabbits (n=20), dogs (n=15), WISTAR rats (n=63), guinea pigs (n=49), and BALB/c mice (n=32). Some animals underwent adrenal autotransplantation. Fluorometric and gel filtration methods were used to assess protein-steroid interactions; total-body γ-irradiation was administered at doses inducing grade IV ARS. Data were statistically processed using Student's t-test.</p><p><strong>Results: </strong>A biphasic adrenocortical response to radiation was observed in most species, whereas rabbits exhibited a monophasic decline in corticosteroid levels. During the peak of ARS, impaired corticosteroid-binding globulin (CBG) function led to increased levels of free, biologically active corticoids, even with normal or reduced total 11-oxycorticosteroids. A consistent radiobiological pattern was established: an increase in the free hormone fraction due to diminished CBG binding capacity. Adrenal autotransplantation prior to irradiation reduced corticoid levels, enhanced CBG binding capacity during ARS, and decreased free corticoid concentrations, resulting in a protective effect and increased radioresistance.</p><p><strong>Conclusion: </strong>The findings underscore the critical role of corticosteroid regulation and CBG functional status in the body's response to radiation exposure. Modulation of adrenal activity and correction of protein-steroid interactions may be considered a promising strategy for enhancing radioresistance.</p>","PeriodicalId":12610,"journal":{"name":"Georgian medical news","volume":" 369","pages":"190-196"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146194811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
MIR-29A, MIR-222 AND MIR-132 IN THE BLOOD PLASMA OF PREGNANT WOMEN AS PREDICTORS OF GESTATIONAL DIABETES. 孕妇血浆中Mir-29a、mir-222和mir-132作为妊娠期糖尿病的预测因子
Q4 Medicine Pub Date : 2025-12-01
L Lachashvili, M Khubua, M Jangavadze, Z Bedinasvili

Background: Gestational Diabetes Mellitus (GDM) is a significant medical problem worldwide and the cause of many complications for the mother and the foetus, in terms of pregnancy management and outcome. Early assessment of the risk of diabetes in pregnant women with hyperglycaemia is particularly important, as it allows timely preventive measures to help avoid potential complications Aim: Our aim was to identify microRNAs that could enable the assessment of diabetes risk in pregnant women with hyperglycaemia.

Methods: The study analyzed the expression of the following microRNAs: miR-132, miR-29a, miR-222, miR-93and miR-17-5p, from the blood samples of pregnant women with hyperglycaemia, with gestational diabetes mellitus, with type 1 or type 2 diabetes and healthy pregnant between 24 and 28 weeks of their pregnancy. The miR-17-5p was used as a reference.

Results: A significant difference in the miR-222 and miR-29a expression level was found in plasma samples. Compared to the control group Among pregnant patients with hyperglycaemia miR-222 and miR-29a in some sample exhibit increased levels while others show reduced levels-suggesting its potential for subgroup differentiation within this population. MiR-93 remains uniformly low in in Diabetes, GDM, Hyperglycaemia groups compared to the control group. A significant difference in the miR-93 expression level was found in plasma samples. miR-132 is also upregulated in GDM and diabetic patients, with the highest levels observed in the diabetic group, compared to the control group. In contrast, its expression fluctuates among pregnant women with hyperglycaemia.

Conclusion: The wide variability in the expression levels of miR-29a, miR-222 and miR-132 suggests that they may serve as useful predictive biomarkers for evaluating diabetes risk in hyperglycemic pregnant women. Further studies involving longitudinal follow-up of hyperglycaemic pregnant women are needed to determine the predictive value of these microRNAs.

背景:妊娠期糖尿病(GDM)是世界范围内的一个重要医学问题,在妊娠管理和结局方面,它会导致母亲和胎儿的许多并发症。早期评估高血糖孕妇的糖尿病风险尤为重要,因为它可以及时采取预防措施,帮助避免潜在的并发症。目的:我们的目的是识别能够评估高血糖孕妇糖尿病风险的microrna。方法:本研究分析了在妊娠24 ~ 28周的高血糖、妊娠期糖尿病、1型或2型糖尿病和健康孕妇血液样本中miR-132、miR-29a、miR-222、mir -93和miR-17-5p的表达情况。以miR-17-5p为参照。结果:miR-222和miR-29a在血浆样品中的表达水平有显著差异。与对照组相比,在高血糖孕妇中,miR-222和miR-29a在一些样本中表现出水平升高,而另一些样本则表现出水平降低,这表明其在该人群中具有亚群分化的潜力。与对照组相比,在糖尿病组、GDM组和高血糖组中,MiR-93保持一致的低水平。血浆样品中miR-93的表达水平有显著差异。miR-132在GDM和糖尿病患者中也上调,与对照组相比,糖尿病组的miR-132水平最高。相反,它的表达在高血糖孕妇中是波动的。结论:miR-29a、miR-222和miR-132表达水平的广泛变异性表明,它们可能作为评估高血糖孕妇糖尿病风险的有用预测性生物标志物。需要对高血糖孕妇进行进一步的纵向随访研究,以确定这些microrna的预测价值。
{"title":"MIR-29A, MIR-222 AND MIR-132 IN THE BLOOD PLASMA OF PREGNANT WOMEN AS PREDICTORS OF GESTATIONAL DIABETES.","authors":"L Lachashvili, M Khubua, M Jangavadze, Z Bedinasvili","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Gestational Diabetes Mellitus (GDM) is a significant medical problem worldwide and the cause of many complications for the mother and the foetus, in terms of pregnancy management and outcome. Early assessment of the risk of diabetes in pregnant women with hyperglycaemia is particularly important, as it allows timely preventive measures to help avoid potential complications Aim: Our aim was to identify microRNAs that could enable the assessment of diabetes risk in pregnant women with hyperglycaemia.</p><p><strong>Methods: </strong>The study analyzed the expression of the following microRNAs: miR-132, miR-29a, miR-222, miR-93and miR-17-5p, from the blood samples of pregnant women with hyperglycaemia, with gestational diabetes mellitus, with type 1 or type 2 diabetes and healthy pregnant between 24 and 28 weeks of their pregnancy. The miR-17-5p was used as a reference.</p><p><strong>Results: </strong>A significant difference in the miR-222 and miR-29a expression level was found in plasma samples. Compared to the control group Among pregnant patients with hyperglycaemia miR-222 and miR-29a in some sample exhibit increased levels while others show reduced levels-suggesting its potential for subgroup differentiation within this population. MiR-93 remains uniformly low in in Diabetes, GDM, Hyperglycaemia groups compared to the control group. A significant difference in the miR-93 expression level was found in plasma samples. miR-132 is also upregulated in GDM and diabetic patients, with the highest levels observed in the diabetic group, compared to the control group. In contrast, its expression fluctuates among pregnant women with hyperglycaemia.</p><p><strong>Conclusion: </strong>The wide variability in the expression levels of miR-29a, miR-222 and miR-132 suggests that they may serve as useful predictive biomarkers for evaluating diabetes risk in hyperglycemic pregnant women. Further studies involving longitudinal follow-up of hyperglycaemic pregnant women are needed to determine the predictive value of these microRNAs.</p>","PeriodicalId":12610,"journal":{"name":"Georgian medical news","volume":" 369","pages":"261-265"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146194816","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ASSESSMENT OF CLINICAL SYMPTOMS OF ACUTE TOXICITY FOLLOWING THE IMPLANTATION OF A NANOCELLULOSE-BASED BIOCOMPOSITE. 纳米纤维素基生物复合材料植入后急性毒性临床症状评估
Q4 Medicine Pub Date : 2025-12-01
M Rashova, S Akhmetova, B Tuleubaev, D Turebekova, A Koshanova, A Omenov, B Kambyl, Y Kossilova

Introduction: The study of acute toxicity is considered an integral part of any medical substance's preclinical evaluation. Changes in the psycho-emotional state are among the important indicators of the neurotoxic effects of various substances on animals and humans. Non-conflict methods of research are gaining increasing popularity as the most humane approaches with respect to animals, among which methods based on ethological approaches play a central role.

Materials and methods: A nanocellulose-based biocomposite was used as the implantable material. The study was conducted on 25 rats and included the formation of a defect in the mid-diaphysis of the femur followed by filling with either the biocomposite (10) or an autologous blood clot (10). Additionally, implantation into soft tissues was performed (5). The animals were observed for 14 days, during which clinical symptoms were assessed and open field and elevated plus maze tests were conducted.

Results: The nanocellulose-based biocomposite did not exhibit pyrogenic activity when implanted into bone and soft tissues. Assessment of several behavioral acts and states revealed no statistically significant differences in locomotor and exploratory activity between the experimental and control groups. The analysis of the indicators shows that the tested substance does not exert an acute toxic effect on the nervous system.

急性毒性研究被认为是任何药物临床前评估的一个组成部分。心理情绪状态的变化是各种物质对动物和人的神经毒性作用的重要指标之一。非冲突研究方法作为对动物最人道的研究方法越来越受欢迎,其中基于动物行为学方法的研究方法起着核心作用。材料与方法:采用纳米纤维素基生物复合材料作为植入材料。该研究在25只大鼠身上进行,包括在股骨中段形成缺损,然后用生物复合材料(10)或自体血凝块(10)填充。此外,植入软组织(5)。观察动物14 d,评估临床症状,并进行开阔场和升高加迷宫试验。结果:纳米纤维素基生物复合材料在骨和软组织植入时不表现出热原活性。对一些行为行为和状态的评估显示,实验组和对照组在运动和探索活动方面没有统计学上的显著差异。各项指标分析表明,试验物质对神经系统不产生急性毒性作用。
{"title":"ASSESSMENT OF CLINICAL SYMPTOMS OF ACUTE TOXICITY FOLLOWING THE IMPLANTATION OF A NANOCELLULOSE-BASED BIOCOMPOSITE.","authors":"M Rashova, S Akhmetova, B Tuleubaev, D Turebekova, A Koshanova, A Omenov, B Kambyl, Y Kossilova","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>The study of acute toxicity is considered an integral part of any medical substance's preclinical evaluation. Changes in the psycho-emotional state are among the important indicators of the neurotoxic effects of various substances on animals and humans. Non-conflict methods of research are gaining increasing popularity as the most humane approaches with respect to animals, among which methods based on ethological approaches play a central role.</p><p><strong>Materials and methods: </strong>A nanocellulose-based biocomposite was used as the implantable material. The study was conducted on 25 rats and included the formation of a defect in the mid-diaphysis of the femur followed by filling with either the biocomposite (10) or an autologous blood clot (10). Additionally, implantation into soft tissues was performed (5). The animals were observed for 14 days, during which clinical symptoms were assessed and open field and elevated plus maze tests were conducted.</p><p><strong>Results: </strong>The nanocellulose-based biocomposite did not exhibit pyrogenic activity when implanted into bone and soft tissues. Assessment of several behavioral acts and states revealed no statistically significant differences in locomotor and exploratory activity between the experimental and control groups. The analysis of the indicators shows that the tested substance does not exert an acute toxic effect on the nervous system.</p>","PeriodicalId":12610,"journal":{"name":"Georgian medical news","volume":" 369","pages":"127-137"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146194820","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PROTECTION OF CONSUMER RIGHTS IN THE FIELD OF ELECTRONIC COMMERCE OF MEDICINES. 药品电子商务领域的消费者权益保护。
Q4 Medicine Pub Date : 2025-12-01
O Markova, O Safonchyk, I Orlovska, O Kovalchuk, A Sukharieva, S Myrza, V Keidaliuk

Background: The development of e-pharmacies has significantly expanded public access to pharmaceutical products. At the same time, the rapid growth of e-commerce, the globalization of digital services and the expansion of cross-border trade in medicines have created new risks for consumers. These include violations of the conditions of storage and transportation of medicines, distribution of low-quality or counterfeit products, increased cases of self-medication, uncontrolled or illegal interference by third parties in the delivery process, etc. Aim: The purpose of the study is to analyze legal challenges and improve consumer protection mechanisms in the field of electronic commerce of medicines at the national and international levels.

Materials and methods: The study applies an interdisciplinary approach combining doctrinal legal analysis, comparative legal methodology, and empirical review of international regulatory practices. Legal acts, WHO and EU documents, FDA guidelines, and statistical data were examined to identify best practices for consumer protection in the field of e-commerce in medicines.

Results: The results of the study indicate that the legal regulation of relations in the field of electronic pharmaceutical services in the legislations of many countries is insufficient. It is emphasized that fragmented legal regulation, lack of harmonized international standards and insufficient supervision in the field of medicines circulation pose a significant threat to the health, safety and privacy of consumers.

Conclusions: It is concluded that effective consumer protection of digital services requires strengthening of regulatory requirements for e-commerce in medicines, in particular, introduction of clear rules for registration and licensing of online pharmacies, regulation of creation of relevant web resources, protection of personal data of consumers, etc. The author proposes a set of legal and institutional measures aimed at ensuring effective protection of the rights of consumers using the services of online pharmacies.

背景:电子药店的发展极大地扩大了公众获取药品的渠道。与此同时,电子商务的快速发展、数字服务的全球化和药品跨境贸易的扩大也给消费者带来了新的风险。这些问题包括违反药品储存和运输条件、分销低质量或假冒产品、自行用药案件增加、第三方在交付过程中不受控制或非法干预等。目的:本研究的目的是在国家和国际层面分析药品电子商务领域的法律挑战和完善消费者保护机制。材料和方法:本研究采用跨学科的方法,结合理论法律分析、比较法律方法和国际监管实践的实证审查。审查了法律行为、世卫组织和欧盟文件、FDA指南和统计数据,以确定药品电子商务领域保护消费者的最佳做法。结果:研究结果表明,许多国家的立法对电子医药服务领域关系的法律规制不足。报告强调,在药品流通领域,分散的法律管制、缺乏统一的国际标准和监督不足对消费者的健康、安全和隐私构成重大威胁。结论:有效的数字服务消费者保护需要加强对药品电子商务的监管要求,特别是对网上药店的注册和许可制定明确的规则,对相关网络资源的创建进行监管,对消费者个人数据的保护等。笔者提出了一套法律和制度措施,旨在确保有效保护消费者使用网络药店服务的权利。
{"title":"PROTECTION OF CONSUMER RIGHTS IN THE FIELD OF ELECTRONIC COMMERCE OF MEDICINES.","authors":"O Markova, O Safonchyk, I Orlovska, O Kovalchuk, A Sukharieva, S Myrza, V Keidaliuk","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>The development of e-pharmacies has significantly expanded public access to pharmaceutical products. At the same time, the rapid growth of e-commerce, the globalization of digital services and the expansion of cross-border trade in medicines have created new risks for consumers. These include violations of the conditions of storage and transportation of medicines, distribution of low-quality or counterfeit products, increased cases of self-medication, uncontrolled or illegal interference by third parties in the delivery process, etc. Aim: The purpose of the study is to analyze legal challenges and improve consumer protection mechanisms in the field of electronic commerce of medicines at the national and international levels.</p><p><strong>Materials and methods: </strong>The study applies an interdisciplinary approach combining doctrinal legal analysis, comparative legal methodology, and empirical review of international regulatory practices. Legal acts, WHO and EU documents, FDA guidelines, and statistical data were examined to identify best practices for consumer protection in the field of e-commerce in medicines.</p><p><strong>Results: </strong>The results of the study indicate that the legal regulation of relations in the field of electronic pharmaceutical services in the legislations of many countries is insufficient. It is emphasized that fragmented legal regulation, lack of harmonized international standards and insufficient supervision in the field of medicines circulation pose a significant threat to the health, safety and privacy of consumers.</p><p><strong>Conclusions: </strong>It is concluded that effective consumer protection of digital services requires strengthening of regulatory requirements for e-commerce in medicines, in particular, introduction of clear rules for registration and licensing of online pharmacies, regulation of creation of relevant web resources, protection of personal data of consumers, etc. The author proposes a set of legal and institutional measures aimed at ensuring effective protection of the rights of consumers using the services of online pharmacies.</p>","PeriodicalId":12610,"journal":{"name":"Georgian medical news","volume":" 369","pages":"180-187"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146194235","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
OMEGA-3 POLYUNSATURATED FATTY ACIDS AND HYPERTENSION: A REVIEW OF VASOACTIVE MECHANISMS AND IMPLICATIONS FOR CARDIOVASCULAR DISEASE. Omega-3多不饱和脂肪酸与高血压:血管活性机制及其对心血管疾病的影响
Q4 Medicine Pub Date : 2025-12-01
M Jawhar, H Zainal, S Harun, B Saeed

Background and aim: Hypertension is an unparalleled risk factor among cardiovascular diseases (CVD) and has been reported to target over 1.4 billion people globally. The Omega-3 polyunsaturated fatty acids (PUFAs), especially the eicosapentaenoic acid (EPA) and the docosahexaenoic acid (DHA) have been put forward as possible non-pharmacological interventions to control blood pressure because they are known to be vasoactive. The purpose of the systematic review was to summarize available evidence on the vasoactive properties of omega-3 PUFAs, and how these properties apply in managing hypertension and reduction of cardiovascular risk.

Methods: Systematic review was done in compliance with the PRISMA guidelines. The search in PubMed, Scopus, and Web of Science was conducted to identify the publications published between 2010 and 2025. Inclusion criteria were randomized controlled trials, cohort studies, and other related meta-analyses on the effect of EPA and/or DHA on blood pressure, and endothelial function, inflammation, lipid metabolism, and cardiovascular outcomes. Synthesis of data was done in the form of systematic narrative without quantitative pooling.

Results: Randomized controlled trial evidence has shown that omega-3 PUFA supplementation is linked with slight systolic and diastolic blood pressure decreases especially in hypertensive or those with high cardiometabolic risk persons. These effects have been shown to mediate via enhancement of endothelial nitric oxide bioavailability, reduction of vascular inflammation and positive remodeling of lipid profiles. Diversity of the outcomes of the studies was noticed and probably it is the difference in dosage, ratios of EPA:DHA, duration of the intervention, and the population specifics at the baseline.

Conclusion: Omega-3 PUFAs have shown promise as supplemental agents in the process of controlling hypertension and prevention of cardiovascular disease by a variety of complementary vasoactive pathways. Nonetheless, the heterogeneity of the studies does not allow conclusive findings on the best dosing strategies. Standardized hypertension-oriented large-scale randomized controlled trials conducted in the future are justified to improve clinical practice.

背景和目的:高血压是心血管疾病(CVD)中无与伦比的危险因素,据报道,全球有超过14亿人患有高血压。Omega-3多不饱和脂肪酸(PUFAs),特别是二十碳五烯酸(EPA)和二十二碳六烯酸(DHA)已被提出作为可能的非药物干预措施来控制血压,因为它们已知具有血管活性。本系统综述的目的是总结现有的关于omega-3 PUFAs血管活性特性的证据,以及这些特性如何应用于控制高血压和降低心血管风险。方法:按照PRISMA指南进行系统评价。在PubMed, Scopus和Web of Science中进行了搜索,以确定2010年至2025年之间发表的出版物。纳入标准是随机对照试验、队列研究和其他有关EPA和/或DHA对血压、内皮功能、炎症、脂质代谢和心血管结局影响的荟萃分析。数据的综合以系统叙述的形式完成,没有定量汇集。结果:随机对照试验证据表明,补充omega-3 PUFA与轻微的收缩压和舒张压降低有关,特别是在高血压或心脏代谢高风险人群中。这些作用已被证明通过增强内皮一氧化氮的生物利用度,减少血管炎症和脂质谱的积极重塑来介导。研究结果的多样性被注意到,可能是剂量的差异,EPA:DHA的比例,干预的持续时间,以及基线时的人群特征。结论:Omega-3 PUFAs通过多种互补的血管活性途径在控制高血压和预防心血管疾病的过程中显示出作为补充剂的前景。尽管如此,这些研究的异质性并不能得出最佳给药策略的结论性结论。标准化的面向高血压的大规模随机对照试验将在未来进行,以改善临床实践。
{"title":"OMEGA-3 POLYUNSATURATED FATTY ACIDS AND HYPERTENSION: A REVIEW OF VASOACTIVE MECHANISMS AND IMPLICATIONS FOR CARDIOVASCULAR DISEASE.","authors":"M Jawhar, H Zainal, S Harun, B Saeed","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background and aim: </strong>Hypertension is an unparalleled risk factor among cardiovascular diseases (CVD) and has been reported to target over 1.4 billion people globally. The Omega-3 polyunsaturated fatty acids (PUFAs), especially the eicosapentaenoic acid (EPA) and the docosahexaenoic acid (DHA) have been put forward as possible non-pharmacological interventions to control blood pressure because they are known to be vasoactive. The purpose of the systematic review was to summarize available evidence on the vasoactive properties of omega-3 PUFAs, and how these properties apply in managing hypertension and reduction of cardiovascular risk.</p><p><strong>Methods: </strong>Systematic review was done in compliance with the PRISMA guidelines. The search in PubMed, Scopus, and Web of Science was conducted to identify the publications published between 2010 and 2025. Inclusion criteria were randomized controlled trials, cohort studies, and other related meta-analyses on the effect of EPA and/or DHA on blood pressure, and endothelial function, inflammation, lipid metabolism, and cardiovascular outcomes. Synthesis of data was done in the form of systematic narrative without quantitative pooling.</p><p><strong>Results: </strong>Randomized controlled trial evidence has shown that omega-3 PUFA supplementation is linked with slight systolic and diastolic blood pressure decreases especially in hypertensive or those with high cardiometabolic risk persons. These effects have been shown to mediate via enhancement of endothelial nitric oxide bioavailability, reduction of vascular inflammation and positive remodeling of lipid profiles. Diversity of the outcomes of the studies was noticed and probably it is the difference in dosage, ratios of EPA:DHA, duration of the intervention, and the population specifics at the baseline.</p><p><strong>Conclusion: </strong>Omega-3 PUFAs have shown promise as supplemental agents in the process of controlling hypertension and prevention of cardiovascular disease by a variety of complementary vasoactive pathways. Nonetheless, the heterogeneity of the studies does not allow conclusive findings on the best dosing strategies. Standardized hypertension-oriented large-scale randomized controlled trials conducted in the future are justified to improve clinical practice.</p>","PeriodicalId":12610,"journal":{"name":"Georgian medical news","volume":" 369","pages":"266-271"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146194289","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IMMUNOMODULATORS IN THE TREATMENT OF ATHEROSCLEROSIS AND OTHER CHRONIC HEART DISEASES: PROSPECTS AND RISKS. 免疫调节剂治疗动脉粥样硬化和其他慢性心脏病:前景和风险
Q4 Medicine Pub Date : 2025-12-01
Y Tyravska, D Maltsev, V Moyseyenko, V Reshetylo, V Yakymenko

Introduction: Atherosclerotic cardiovascular diseases remain the leading cause of mortality worldwide, with chronic inflammation driving progression despite traditional lipid-lowering and antiplatelet therapy, leaving substantial residual cardiovascular risk. This study aimed to systematically analyze immunomodulator efficacy and safety in treating atherosclerosis and chronic cardiac diseases, determining therapeutic potential and associated risks.

Methods: A systematic search of Scopus, Web of Science, PubMed, Embase, and the Cochrane Library identified 264 records. After removing 134 duplicates and screening 130 unique records, 74 studies (20 randomized controlled trials, 16 systematic reviews/meta-analyses, 22 prospective cohort studies, 9 retrospective analyses, and 7 experimental studies) were selected that met the inclusion criteria and were included in the qualitative synthesis according to PRISMA 2020.

Results: Three main immunomodulator categories demonstrated cardiovascular efficacy: interleukin-1β inhibitors (canakinumab reduced events by 15%), small anti-inflammatory molecules (colchicine achieved 23-31% risk reduction), and interleukin-6 receptor antagonists (tocilizumab reduced infarct size by 12.4%). However, biological agents showed increased infectious complications, with canakinumab demonstrating statistically significant fatal infection increase. Immunomodulatory therapy represents transformative advancement targeting inflammatory mechanisms beyond lipid reduction. Colchicine emerged as priority drug for clinical implementation given optimal efficacy-cost ratio and favorable safety profile, while biologics face economic barriers exceeding $70,000 annually.

Conclusions: Long-term monitoring of immunosuppressive therapy safety profiles, particularly regarding infectious complications and oncological risks, remains critically important for future large-scale studies requiring decade-long surveillance in diverse populations.

导论:动脉粥样硬化性心血管疾病仍然是世界范围内死亡的主要原因,尽管传统的降脂和抗血小板治疗,慢性炎症驱动进展,留下大量残留的心血管风险。本研究旨在系统分析免疫调节剂治疗动脉粥样硬化和慢性心脏疾病的有效性和安全性,确定治疗潜力和相关风险。方法:系统检索Scopus、Web of Science、PubMed、Embase和Cochrane Library,确定264条记录。在剔除134项重复和筛选130项独特记录后,我们选择了74项符合纳入标准的研究(20项随机对照试验、16项系统评价/荟萃分析、22项前瞻性队列研究、9项回顾性分析和7项实验研究),并根据PRISMA 2020纳入定性综合。结果:三种主要的免疫调节剂类别显示出心血管功效:白介素-1β抑制剂(canakinumab可减少15%的事件),小抗炎分子(秋水仙碱可降低23-31%的风险)和白介素-6受体拮抗剂(tocilizumab可减少12.4%的梗死面积)。然而,生物制剂显示出增加的感染并发症,canakinumab显示有统计学意义的致命感染增加。免疫调节疗法代表了针对炎症机制的变革性进展,而不仅仅是脂质降低。秋水仙碱因其最佳的疗效成本比和良好的安全性而成为临床应用的优先药物,而生物制剂面临每年超过7万美元的经济壁垒。结论:长期监测免疫抑制治疗的安全性,特别是关于感染并发症和肿瘤风险,对于未来需要在不同人群中进行长达十年的监测的大规模研究至关重要。
{"title":"IMMUNOMODULATORS IN THE TREATMENT OF ATHEROSCLEROSIS AND OTHER CHRONIC HEART DISEASES: PROSPECTS AND RISKS.","authors":"Y Tyravska, D Maltsev, V Moyseyenko, V Reshetylo, V Yakymenko","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Atherosclerotic cardiovascular diseases remain the leading cause of mortality worldwide, with chronic inflammation driving progression despite traditional lipid-lowering and antiplatelet therapy, leaving substantial residual cardiovascular risk. This study aimed to systematically analyze immunomodulator efficacy and safety in treating atherosclerosis and chronic cardiac diseases, determining therapeutic potential and associated risks.</p><p><strong>Methods: </strong>A systematic search of Scopus, Web of Science, PubMed, Embase, and the Cochrane Library identified 264 records. After removing 134 duplicates and screening 130 unique records, 74 studies (20 randomized controlled trials, 16 systematic reviews/meta-analyses, 22 prospective cohort studies, 9 retrospective analyses, and 7 experimental studies) were selected that met the inclusion criteria and were included in the qualitative synthesis according to PRISMA 2020.</p><p><strong>Results: </strong>Three main immunomodulator categories demonstrated cardiovascular efficacy: interleukin-1β inhibitors (canakinumab reduced events by 15%), small anti-inflammatory molecules (colchicine achieved 23-31% risk reduction), and interleukin-6 receptor antagonists (tocilizumab reduced infarct size by 12.4%). However, biological agents showed increased infectious complications, with canakinumab demonstrating statistically significant fatal infection increase. Immunomodulatory therapy represents transformative advancement targeting inflammatory mechanisms beyond lipid reduction. Colchicine emerged as priority drug for clinical implementation given optimal efficacy-cost ratio and favorable safety profile, while biologics face economic barriers exceeding $70,000 annually.</p><p><strong>Conclusions: </strong>Long-term monitoring of immunosuppressive therapy safety profiles, particularly regarding infectious complications and oncological risks, remains critically important for future large-scale studies requiring decade-long surveillance in diverse populations.</p>","PeriodicalId":12610,"journal":{"name":"Georgian medical news","volume":" 369","pages":"6-16"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146194736","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ANALYSIS OF RISK FACTORS AND THEIR IMPACT ON BONE HEALTH STATUS IN KAZAKH POPULATIONS. 哈萨克族人群骨健康状况的危险因素及其影响分析
Q4 Medicine Pub Date : 2025-12-01
M Madiyeva, G Bersimbekova, G Kanapiyanova, M Prilutskaya, A Mukanova

Background: Osteoporosis is a serious public health problem worldwide, especially among the aging population. It is characterized by low bone mineral density (BMD), which leads to an increased risk of fractures. Despite the growing burden, data on the prevalence of osteoporosis and related risk factors in Kazakhstan are limited. The purpose of this study was to assess the state of BMD and identify key risk factors associated with osteoporosis among adults aged 45 years and older in the Abay region of Kazakhstan.

Methods: The cross-sectional study was conducted from July 2023 to March 2024 with 367 women. Data collection included measurement of BMD using dual-energy X-ray absorptiometry (DXA), a standardized questionnaire adapted by the International Osteoporosis Foundation, and laboratory tests (vitamin D, calcium, and alkaline phosphatase levels). The participants were grouped by age and BMD status. Statistical analysis included the chi-square criterion or Fisher's exact criterion for categorical variables and the Mann-Whitney U-test or Kruskal-Wallis criterion for continuous variables. Logistic regression was used to study the relationship between low BMD and demographic factors, lifestyle, and nutrition.

Results: Osteopenia and osteoporosis were detected in 25.3% and 21.0% of participants, respectively, and their prevalence was significantly higher among people aged 56-65 years (p<0.004). Regression analysis showed that low BMD was significantly associated with older age (AOR 1.034; p=0.025), weight (AOR 0.975; p=0.071), lower BMI (AOR 0.989; p=0.764).

Conclusions: This study highlights the high prevalence of low BMD among middle-aged and older adults in the Abay region and underscores key modifiable risk factors, including older age, lower BMI, fracture history, and rheumatoid arthritis. These findings are essential for strengthening clinical diagnostic practices and guiding preventive strategies to reduce osteoporosis-related complications in the Kazakh population.

背景:骨质疏松症是世界范围内严重的公共卫生问题,尤其是在老龄化人群中。它的特点是低骨密度(BMD),这导致骨折的风险增加。尽管负担越来越大,但关于哈萨克斯坦骨质疏松症患病率和相关危险因素的数据有限。本研究的目的是评估哈萨克斯坦Abay地区45岁及以上成年人的骨密度状况,并确定与骨质疏松症相关的关键危险因素。方法:横断面研究于2023年7月至2024年3月对367名妇女进行。数据收集包括使用双能x射线吸收仪(DXA)测量骨密度、国际骨质疏松基金会采用的标准化问卷和实验室测试(维生素D、钙和碱性磷酸酶水平)。参与者按年龄和骨密度状况分组。统计分析对分类变量采用卡方标准或Fisher精确标准,对连续变量采用Mann-Whitney u检验或Kruskal-Wallis标准。采用Logistic回归研究低骨密度与人口统计学因素、生活方式和营养的关系。结果:骨量减少和骨质疏松症分别在25.3%和21.0%的参与者中被检测到,其患病率在56-65岁的人群中明显更高(结论:本研究强调了Abay地区中老年人群中低骨密度的高患病率,并强调了关键的可改变的危险因素,包括年龄较大,较低的BMI,骨折史和类风湿关节炎。这些发现对于加强临床诊断实践和指导预防策略以减少哈萨克斯坦人口中骨质疏松相关并发症至关重要。
{"title":"ANALYSIS OF RISK FACTORS AND THEIR IMPACT ON BONE HEALTH STATUS IN KAZAKH POPULATIONS.","authors":"M Madiyeva, G Bersimbekova, G Kanapiyanova, M Prilutskaya, A Mukanova","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Osteoporosis is a serious public health problem worldwide, especially among the aging population. It is characterized by low bone mineral density (BMD), which leads to an increased risk of fractures. Despite the growing burden, data on the prevalence of osteoporosis and related risk factors in Kazakhstan are limited. The purpose of this study was to assess the state of BMD and identify key risk factors associated with osteoporosis among adults aged 45 years and older in the Abay region of Kazakhstan.</p><p><strong>Methods: </strong>The cross-sectional study was conducted from July 2023 to March 2024 with 367 women. Data collection included measurement of BMD using dual-energy X-ray absorptiometry (DXA), a standardized questionnaire adapted by the International Osteoporosis Foundation, and laboratory tests (vitamin D, calcium, and alkaline phosphatase levels). The participants were grouped by age and BMD status. Statistical analysis included the chi-square criterion or Fisher's exact criterion for categorical variables and the Mann-Whitney U-test or Kruskal-Wallis criterion for continuous variables. Logistic regression was used to study the relationship between low BMD and demographic factors, lifestyle, and nutrition.</p><p><strong>Results: </strong>Osteopenia and osteoporosis were detected in 25.3% and 21.0% of participants, respectively, and their prevalence was significantly higher among people aged 56-65 years (p<0.004). Regression analysis showed that low BMD was significantly associated with older age (AOR 1.034; p=0.025), weight (AOR 0.975; p=0.071), lower BMI (AOR 0.989; p=0.764).</p><p><strong>Conclusions: </strong>This study highlights the high prevalence of low BMD among middle-aged and older adults in the Abay region and underscores key modifiable risk factors, including older age, lower BMI, fracture history, and rheumatoid arthritis. These findings are essential for strengthening clinical diagnostic practices and guiding preventive strategies to reduce osteoporosis-related complications in the Kazakh population.</p>","PeriodicalId":12610,"journal":{"name":"Georgian medical news","volume":" 369","pages":"23-30"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146194742","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ASSOCIATION BETWEEN EXERCISE MODALITIES AND GLYCEMIC CONTROL IN TYPE 2 DIABETES. 2型糖尿病患者运动方式与血糖控制的关系
Q4 Medicine Pub Date : 2025-12-01
M Ismail, M Hassan, A Gherdaoui, M Alnaimi, R Altamimi, S Manimaran, M Jallo, R Muthukrishnan, P Kandakurthi, M Jaborova, F Shukurov, Sh Elsiddig, T Yousif, A Babker, A Osman, A Elamin

Background: Type 2 diabetes mellitus is associated with increased cardiovascular risk, with physical inactivity contributing significantly to metabolic dysfunction. This study aimed to investigate the association between physical activity status and cardiometabolic markers in patients with type 2 diabetes mellitus in the United Arab Emirates.

Methods: This cross-sectional study was conducted at Thumbay Labs, UAE, between January and October 2025. A total of 185 participants with type 2 diabetes were stratified into active (at least 150 minutes per week for more than 3 months) (n=99) and sedentary (n=86) groups based on physical activity levels. The active group was further subclassified by exercise type: aerobic (n=70), combined (n=17), and resistance training (n=11). Anthropometric measurements and biochemical parameters including fasting glucose, HbA1c, Fructosamine, fasting insulin, HOMA-IR, and lipid profile were assessed. Mann-Whitney U test, Kruskal-Wallis test, and Spearman's correlation were used for statistical analysis.

Results: The active group demonstrated significantly lower BMI (26.4 vs 28.6 kg/m², p<0.001), fasting glucose (127 vs 149 mg/dl, p<0.001), HbA1c (6.84% vs 8.07%, p<0.001), Fructosamine (303 vs 362 μmol/L, p<0.001), fasting insulin (9.03 vs 10.99 μU/mL, p=0.011), and HOMA-IR (3.0 vs 4.1, p<0.001) compared to the sedentary group. No significant differences were observed in lipid parameters. Among exercise subgroups, resistance training exhibited the most favorable metabolic profile with the lowest HbA1c (6.41%), BMI (23.01 kg/m²), and HOMA-IR (1.9). Correlation analysis revealed significant positive associations between BMI and glycemic markers as well as insulin resistance indices.

Conclusion: Physical activity is associated with significantly better glycemic control, insulin sensitivity, and body composition in patients with type 2 diabetes. Resistance training demonstrated particularly favorable metabolic outcomes; however, limited sample size restrict generalizability. These findings support the integration of regular physical activity into comprehensive diabetes care strategies.

背景:2型糖尿病与心血管风险增加相关,缺乏运动对代谢功能障碍有显著影响。本研究旨在探讨阿拉伯联合酋长国2型糖尿病患者身体活动状况与心脏代谢标志物之间的关系。方法:本横断面研究于2025年1月至10月在阿联酋Thumbay实验室进行。185名2型糖尿病患者根据身体活动水平被分为活动组(每周至少150分钟,持续3个月以上)(n=99)和久坐组(n=86)。活动组按运动类型进一步细分:有氧(n=70)、联合(n=17)和阻力训练(n=11)。评估人体测量和生化参数,包括空腹血糖、糖化血红蛋白、果糖胺、空腹胰岛素、HOMA-IR和血脂。采用Mann-Whitney U检验、Kruskal-Wallis检验和Spearman相关进行统计分析。结果:运动组的BMI显著降低(26.4 vs 28.6 kg/m²)。结论:运动与2型糖尿病患者更好的血糖控制、胰岛素敏感性和身体成分相关。阻力训练显示出特别有利的代谢结果;然而,有限的样本量限制了普遍性。这些发现支持将有规律的体育活动纳入全面的糖尿病护理策略。
{"title":"ASSOCIATION BETWEEN EXERCISE MODALITIES AND GLYCEMIC CONTROL IN TYPE 2 DIABETES.","authors":"M Ismail, M Hassan, A Gherdaoui, M Alnaimi, R Altamimi, S Manimaran, M Jallo, R Muthukrishnan, P Kandakurthi, M Jaborova, F Shukurov, Sh Elsiddig, T Yousif, A Babker, A Osman, A Elamin","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Type 2 diabetes mellitus is associated with increased cardiovascular risk, with physical inactivity contributing significantly to metabolic dysfunction. This study aimed to investigate the association between physical activity status and cardiometabolic markers in patients with type 2 diabetes mellitus in the United Arab Emirates.</p><p><strong>Methods: </strong>This cross-sectional study was conducted at Thumbay Labs, UAE, between January and October 2025. A total of 185 participants with type 2 diabetes were stratified into active (at least 150 minutes per week for more than 3 months) (n=99) and sedentary (n=86) groups based on physical activity levels. The active group was further subclassified by exercise type: aerobic (n=70), combined (n=17), and resistance training (n=11). Anthropometric measurements and biochemical parameters including fasting glucose, HbA1c, Fructosamine, fasting insulin, HOMA-IR, and lipid profile were assessed. Mann-Whitney U test, Kruskal-Wallis test, and Spearman's correlation were used for statistical analysis.</p><p><strong>Results: </strong>The active group demonstrated significantly lower BMI (26.4 vs 28.6 kg/m², p<0.001), fasting glucose (127 vs 149 mg/dl, p<0.001), HbA1c (6.84% vs 8.07%, p<0.001), Fructosamine (303 vs 362 μmol/L, p<0.001), fasting insulin (9.03 vs 10.99 μU/mL, p=0.011), and HOMA-IR (3.0 vs 4.1, p<0.001) compared to the sedentary group. No significant differences were observed in lipid parameters. Among exercise subgroups, resistance training exhibited the most favorable metabolic profile with the lowest HbA1c (6.41%), BMI (23.01 kg/m²), and HOMA-IR (1.9). Correlation analysis revealed significant positive associations between BMI and glycemic markers as well as insulin resistance indices.</p><p><strong>Conclusion: </strong>Physical activity is associated with significantly better glycemic control, insulin sensitivity, and body composition in patients with type 2 diabetes. Resistance training demonstrated particularly favorable metabolic outcomes; however, limited sample size restrict generalizability. These findings support the integration of regular physical activity into comprehensive diabetes care strategies.</p>","PeriodicalId":12610,"journal":{"name":"Georgian medical news","volume":" 369","pages":"217-223"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146194748","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Georgian medical news
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1